BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 7854979)

  • 1. Expression and characterization of a recombinant human parathyroid hormone partial agonist with antagonistic properties: Gly-hPTH(-1-->+84).
    Olstad OK; Jemtland R; Loseth OP; Bringhurst FR; Gautvik KM
    Peptides; 1995; 16(6):1031-7. PubMed ID: 8532584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and cyclic AMP stimulation by N-terminally deleted human PTHs (3-84 and 4-84) in a homologous ligand receptor system.
    Olstad OK; Reppe S; Loseth OP; Jemtland R; Gautvik KM
    J Bone Miner Res; 1997 Sep; 12(9):1348-57. PubMed ID: 9286750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-1 parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptors activate phospholipase C in response to carboxyl-truncated analogs of PTH(1-34).
    Takasu H; Bringhurst FR
    Endocrinology; 1998 Oct; 139(10):4293-9. PubMed ID: 9751512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells.
    Bringhurst FR; Juppner H; Guo J; Urena P; Potts JT; Kronenberg HM; Abou-Samra AB; Segre GV
    Endocrinology; 1993 May; 132(5):2090-8. PubMed ID: 8386606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
    Behar V; Pines M; Nakamoto C; Greenberg Z; Bisello A; Stueckle SM; Bessalle R; Usdin TB; Chorev M; Rosenblatt M; Suva LJ
    Endocrinology; 1996 Jul; 137(7):2748-57. PubMed ID: 8770894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in binding affinities of human PTH(1-84) do not alter biological potency: a comparison between chemically synthesized hormone, natural and mutant forms.
    Olstad OK; Morrison NE; Jemtland R; Jüppner H; Segre GV; Gautvik KM
    Peptides; 1994; 15(7):1261-5. PubMed ID: 7854979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications.
    Brossard JH; Yamamoto LN; D'Amour P
    Semin Dial; 2002; 15(3):196-201. PubMed ID: 12100458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
    Gao P; D'Amour P
    Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.